microfluidic platform Search Results


92
Revvity labchip gx touch ht microfluidics platform
Labchip Gx Touch Ht Microfluidics Platform, supplied by Revvity, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/labchip gx touch ht microfluidics platform/product/Revvity
Average 92 stars, based on 1 article reviews
labchip gx touch ht microfluidics platform - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics blood-brain barrier microfluidic platform b 3 c
Blood Brain Barrier Microfluidic Platform B 3 C, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/blood-brain barrier microfluidic platform b 3 c/product/BioMimetic Therapeutics
Average 90 stars, based on 1 article reviews
blood-brain barrier microfluidic platform b 3 c - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Mission Bio microfluidic-based encapsulation platform
Microfluidic Based Encapsulation Platform, supplied by Mission Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microfluidic-based encapsulation platform/product/Mission Bio
Average 90 stars, based on 1 article reviews
microfluidic-based encapsulation platform - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Xona Microfluidics lateral-channel platform netri
Lateral Channel Platform Netri, supplied by Xona Microfluidics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lateral-channel platform netri/product/Xona Microfluidics
Average 90 stars, based on 1 article reviews
lateral-channel platform netri - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
MicroFluidic Systems microengineered platforms combining cells and microfluidic systems
Microengineered Platforms Combining Cells And Microfluidic Systems, supplied by MicroFluidic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microengineered platforms combining cells and microfluidic systems/product/MicroFluidic Systems
Average 90 stars, based on 1 article reviews
microengineered platforms combining cells and microfluidic systems - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
MicroFluidic Systems filtration-assisted magnetofluidic cartridge qpcr platform
Filtration Assisted Magnetofluidic Cartridge Qpcr Platform, supplied by MicroFluidic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/filtration-assisted magnetofluidic cartridge qpcr platform/product/MicroFluidic Systems
Average 90 stars, based on 1 article reviews
filtration-assisted magnetofluidic cartridge qpcr platform - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Biomark Inc hd microfluidics platform
Hd Microfluidics Platform, supplied by Biomark Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hd microfluidics platform/product/Biomark Inc
Average 90 stars, based on 1 article reviews
hd microfluidics platform - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
CellASIC Corporation onix microfluidic platform
An experiment schematic is included in the panel. BCG darG-sgRNA and BCG carrying an empty vector were pretreated for 48 h with 200 ng/ml ATC, then loaded into a <t>microfluidic</t> device. The bacteria were imaged every hour for 59 h, with continued ATC treatment. BCG-vector control bacilli divide over 59 h ( A – C ), whereas BCG darG-sgRNA stop dividing and elongate ( D – F ). An example is circled in each treatment. .
Onix Microfluidic Platform, supplied by CellASIC Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/onix microfluidic platform/product/CellASIC Corporation
Average 90 stars, based on 1 article reviews
onix microfluidic platform - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics microfluidic platforms
An experiment schematic is included in the panel. BCG darG-sgRNA and BCG carrying an empty vector were pretreated for 48 h with 200 ng/ml ATC, then loaded into a <t>microfluidic</t> device. The bacteria were imaged every hour for 59 h, with continued ATC treatment. BCG-vector control bacilli divide over 59 h ( A – C ), whereas BCG darG-sgRNA stop dividing and elongate ( D – F ). An example is circled in each treatment. .
Microfluidic Platforms, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microfluidic platforms/product/BioMimetic Therapeutics
Average 90 stars, based on 1 article reviews
microfluidic platforms - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics microfluidic selection platform
An experiment schematic is included in the panel. BCG darG-sgRNA and BCG carrying an empty vector were pretreated for 48 h with 200 ng/ml ATC, then loaded into a <t>microfluidic</t> device. The bacteria were imaged every hour for 59 h, with continued ATC treatment. BCG-vector control bacilli divide over 59 h ( A – C ), whereas BCG darG-sgRNA stop dividing and elongate ( D – F ). An example is circled in each treatment. .
Microfluidic Selection Platform, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microfluidic selection platform/product/BioMimetic Therapeutics
Average 90 stars, based on 1 article reviews
microfluidic selection platform - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Nortis Inc microfluidic platform
An experiment schematic is included in the panel. BCG darG-sgRNA and BCG carrying an empty vector were pretreated for 48 h with 200 ng/ml ATC, then loaded into a <t>microfluidic</t> device. The bacteria were imaged every hour for 59 h, with continued ATC treatment. BCG-vector control bacilli divide over 59 h ( A – C ), whereas BCG darG-sgRNA stop dividing and elongate ( D – F ). An example is circled in each treatment. .
Microfluidic Platform, supplied by Nortis Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microfluidic platform/product/Nortis Inc
Average 90 stars, based on 1 article reviews
microfluidic platform - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Cellix Limited flow-based cellix instruments
An experiment schematic is included in the panel. BCG darG-sgRNA and BCG carrying an empty vector were pretreated for 48 h with 200 ng/ml ATC, then loaded into a <t>microfluidic</t> device. The bacteria were imaged every hour for 59 h, with continued ATC treatment. BCG-vector control bacilli divide over 59 h ( A – C ), whereas BCG darG-sgRNA stop dividing and elongate ( D – F ). An example is circled in each treatment. .
Flow Based Cellix Instruments, supplied by Cellix Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/flow-based cellix instruments/product/Cellix Limited
Average 90 stars, based on 1 article reviews
flow-based cellix instruments - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


An experiment schematic is included in the panel. BCG darG-sgRNA and BCG carrying an empty vector were pretreated for 48 h with 200 ng/ml ATC, then loaded into a microfluidic device. The bacteria were imaged every hour for 59 h, with continued ATC treatment. BCG-vector control bacilli divide over 59 h ( A – C ), whereas BCG darG-sgRNA stop dividing and elongate ( D – F ). An example is circled in each treatment. .

Journal: The EMBO Journal

Article Title: Control of replication and gene expression by ADP-ribosylation of DNA in Mycobacterium tuberculosis

doi: 10.1038/s44318-025-00451-y

Figure Lengend Snippet: An experiment schematic is included in the panel. BCG darG-sgRNA and BCG carrying an empty vector were pretreated for 48 h with 200 ng/ml ATC, then loaded into a microfluidic device. The bacteria were imaged every hour for 59 h, with continued ATC treatment. BCG-vector control bacilli divide over 59 h ( A – C ), whereas BCG darG-sgRNA stop dividing and elongate ( D – F ). An example is circled in each treatment. .

Article Snippet: For microscopy experiments, minimally darG -silenced bacilli were harvested after 7 days of treatment and loaded into a CellAsic ONIX Microfluidic Platform using a plate for bacterial cells.

Techniques: Plasmid Preparation, Bacteria, Control

An experiment schematic is included in the panel. BCG darG-sgRNA were minimally inhibited with ATC in a microtitre plate for 7 days, and loaded into a microfluidic device ( A ). After 12 h, ATC was washed out of the device ( B ). The bacterium marked with a white arrow was followed over time ( C ). After 16 h in fresh medium, division occurs at one pole ( D – F ). After 58 in fresh medium, branching occurs at the other pole ( G ) but is followed by swelling ( H ) and necrosis ( I ).

Journal: The EMBO Journal

Article Title: Control of replication and gene expression by ADP-ribosylation of DNA in Mycobacterium tuberculosis

doi: 10.1038/s44318-025-00451-y

Figure Lengend Snippet: An experiment schematic is included in the panel. BCG darG-sgRNA were minimally inhibited with ATC in a microtitre plate for 7 days, and loaded into a microfluidic device ( A ). After 12 h, ATC was washed out of the device ( B ). The bacterium marked with a white arrow was followed over time ( C ). After 16 h in fresh medium, division occurs at one pole ( D – F ). After 58 in fresh medium, branching occurs at the other pole ( G ) but is followed by swelling ( H ) and necrosis ( I ).

Article Snippet: For microscopy experiments, minimally darG -silenced bacilli were harvested after 7 days of treatment and loaded into a CellAsic ONIX Microfluidic Platform using a plate for bacterial cells.

Techniques: